Susac syndrome complicating a SARS-CoV-2 infection

J Neurovirol. 2021 Dec;27(6):954-959. doi: 10.1007/s13365-021-01022-7. Epub 2021 Nov 4.

Abstract

In 2020 the world was captivated by the COVID-19 pandemic. Current scientific evidence suggests an interaction of SARS-CoV-2 and the human immune system. Multiple cases were reported of patients with COVID-19 presenting with encephalopathy, confusion or agitation, stroke, and other neurologic symptoms. We present a case of a 40-year-old man diagnosed with Susac syndrome after COVID-19, presenting with acute sensorineural hearing loss, encephalopathy, a splenial "snowball-like" lesion, and branch retinal artery occlusions with distal arterial wall hyperintensity. Although the pathophysiology of Susac syndrome remains unclear, this case is in line with the ongoing debate about the influence of SARS-CoV-2 on the human immune system. Corticosteroid treatment was initiated, followed by two treatments with rituximab, with clinical improvement of the symptomatology. Maintenance treatment currently consists of mycophenolic acid (MPA). Future research will need to focus on the underlying mechanisms for COVID-19-associated (autoimmune) complications.

Keywords: COVID-19; Snowball-like lesion; Susac syndrome.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • COVID-19* / complications
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Pandemics
  • SARS-CoV-2
  • Susac Syndrome* / complications
  • Susac Syndrome* / diagnosis
  • Susac Syndrome* / drug therapy